Publications by authors named "Hans Erickson"

Claim this Profile
R
Rights of Immigration Detainees to Acute Medical Care.
Lawrence A Haber, Hans P Erickson, Peter L Markowitz

JAMA Intern Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can my incarcerated patient discharge against medical advice?
Lawrence A Haber, Hans P Erickson, Jennifer R Lyden

J Hosp Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staying against medical advice.
Lawrence A Haber, Hans P Erickson, Anil N Makam

J Hosp Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the Suture Pullout Force for Human Small Bowel.
Alex T Gong, Shi-Wen Olivia Yau, Hans B Erickson, Rudolph J Toepfer, Jessica Zhang

J Biomech Eng· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease.
Matthew Stauder, Elizabeth B Klerman, Wei Wang, Hans Erickson, Aleksandar Videnovic

Parkinsonism Relat Disord· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shackling in the Hospital.
Lawrence A Haber, Lisa A Pratt, Hans P Erickson, Brie A Williams

J Gen Intern Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calicheamicin Antibody-Drug Conjugates with Improved Properties.
Breanna S Vollmar, Chris Frantz, Melissa M Schutten, Fiona Zhong, Geoffrey Del Rosario, Hans K Erickson

Mol Cancer Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Care for Patients Who Are Incarcerated: A Review.
Lawrence A Haber, Hans P Erickson, Sumant R Ranji, Gabriel M Ortiz, Lisa A Pratt

JAMA Intern Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation.
Nicholas C Yoder, Chen Bai, Daniel Tavares, Wayne C Widdison, Kathleen R Whiteman, Hans K Erickson

Mol Pharm· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug Conjugates.
Byoung-Chul Lee, Cecile Chalouni, Sophia Doll, Sam C Nalle, Martine Darwish, Hans Erickson

Bioconjug Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers.
Rachana Ohri, Sunil Bhakta, Aimee Fourie-O'Donohue, Josefa Dela Cruz-Chuh, Siao Ping Tsai, Hans Erickson

Bioconjug Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attachment Site Cysteine Thiol pK Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody-Drug Conjugates.
Breanna S Vollmar, Binqing Wei, Rachana Ohri, Jianhui Zhou, Jintang He, Hans K Erickson

Bioconjug Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Light therapy for multiple sclerosis-associated fatigue: Study protocol for a randomized controlled trial.
Farrah J Mateen, Natalie C Manalo, Sara J Grundy, Melissa A Houghton, Gladia C Hotan, Hans Erickson

Medicine (Baltimore)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.
Xiuxia Sun, Jose F Ponte, Nicholas C Yoder, Rassol Laleau, Jennifer Coccia, Hans K Erickson

Bioconjug Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.
Kalli C Catcott, Molly A McShea, Carl Uli Bialucha, Kathy L Miller, Stuart W Hicks, Hans K Erickson

MAbs· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft Mice.
Yong Ma, S Cyrus Khojasteh, Cornelis E C A Hop, Hans K Erickson, Andrew Polson

Drug Metab Dispos· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates.
Donglu Zhang, Shang-Fan Yu, Yong Ma, Keyang Xu, Peter S Dragovich, Hans K Erickson

Drug Metab Dispos· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
Jose F Ponte, Xiuxia Sun, Nicholas C Yoder, Nathan Fishkin, Rassol Laleau, Hans K Erickson

Bioconjug Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells.
Rajeeva Singh, Yulius Y Setiady, Jose Ponte, Yelena V Kovtun, Katharine C Lai, Hans K Erickson

Mol Cancer Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation.
E Erica Hong, Hans Erickson, Robert J Lutz, Kathleen R Whiteman, Gregory Jones

Mol Pharm· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates.
Russ Wada, Hans K Erickson, Gail D Lewis Phillips, Carmela A Provenzano, Douglas D Leipold

Cancer Chemother Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies.
Jutta Deckert, Peter U Park, Sharon Chicklas, Yong Yi, Min Li, Hans K Erickson

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates: May 24, 2012, San Diego, CA.
Karen Thudium, Sanela Bilic, Douglas Leipold, William Mallet, Surinder Kaur, Hans Erickson

MAbs· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADME of antibody-maytansinoid conjugates.
Hans K Erickson, John M Lambert

AAPS J· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of different linkers on target cell catabolism and pharmacokinetics/pharmacodynamics of trastuzumab maytansinoid conjugates.
Hans K Erickson, Gail D Lewis Phillips, Douglas D Leipold, Carmela A Provenzano, Elaine Mai

Mol Cancer Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis